The Virgin Islands Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legal agreement that establishes the terms and conditions for the use and commercialization of intellectual property developed by the University and licensed to Gentling, Inc. This agreement grants Gentling, Inc. the rights to develop, market, and sell products that are based on or incorporate the intellectual property owned by the University. The keyword "Virgin Islands Collateral License Agreement" refers to the specific agreement between the two parties that is governed by the laws of the Virgin Islands. It is important to note that the specifics of this agreement may vary depending on the jurisdiction and the nature of the intellectual property being licensed. The objective of the Virgin Islands Collateral License Agreement is to protect the interests of both parties by clearly defining their rights and responsibilities regarding the intellectual property. This includes considerations such as ownership, confidentiality, financial arrangements, patent prosecution, and dispute resolution. It is possible that there may be variations or different types of Virgin Islands Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center, depending on the specific intellectual property being licensed. For example, there could be agreements specific to patents, trademarks, copyrights, or other forms of intellectual property. In conclusion, the Virgin Islands Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center outlines the terms and conditions of licensing intellectual property for commercial purposes. These agreements play a vital role in facilitating the collaboration and protection of valuable intellectual assets between academic institutions and corporate entities.